Search Results - "Gnörich, Johannes"
-
1
Astroglial glucose uptake determines brain FDG-PET alterations and metabolic connectivity during healthy aging in mice
Published in NeuroImage (Orlando, Fla.) (15-10-2024)“…•Cellular sources of FDG-PET signals were evaluated during aging in healthy mice.•Neuronal glucose uptake peaks at 12 months, then declines.•Astroglial glucose…”
Get full text
Journal Article -
2
Validity and value of metabolic connectivity in mouse models of β-amyloid and tauopathy
Published in NeuroImage (Orlando, Fla.) (01-02-2024)“…Among functional imaging methods, metabolic connectivity (MC) is increasingly used for investigation of regional network changes to examine the pathophysiology…”
Get full text
Journal Article -
3
Towards multicenter β-amyloid PET imaging in mouse models: A triple scanner head-to-head comparison
Published in NeuroImage (Orlando, Fla.) (15-08-2024)“…•Three distinct small animal PET scanners show high agreement in Aβ-PET quantification, crucial for multicentric AD research.•Variability in scanner…”
Get full text
Journal Article -
4
Depletion and activation of microglia impact metabolic connectivity of the mouse brain
Published in Journal of neuroinflammation (24-02-2023)“…We aimed to investigate the impact of microglial activity and microglial FDG uptake on metabolic connectivity, since microglial activation states determine…”
Get full text
Journal Article -
5
Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [18F]UCB-H PET imaging
Published in NeuroImage clinical (01-01-2023)“…•[18F]UCB-H was evaluated as a preclinical biomarker of synapse density in Alzheimer’s disease (AD) models.•Decreased PET signals reflected synapse loss in…”
Get full text
Journal Article -
6
Loss of TMEM106B potentiates lysosomal and FTLD‐like pathology in progranulin‐deficient mice
Published in EMBO reports (05-10-2020)“…Single nucleotide polymorphisms (SNPs) in TMEM106B encoding the lysosomal type II transmembrane protein 106B increase the risk for frontotemporal lobar…”
Get full text
Journal Article -
7
A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models
Published in Nature neuroscience (01-03-2023)“…Loss-of-function variants of TREM2 are associated with increased risk of Alzheimer’s disease (AD), suggesting that activation of this innate immune receptor…”
Get full text
Journal Article -
8
Loss of TREM2 rescues hyperactivation of microglia, but not lysosomal deficits and neurotoxicity in models of progranulin deficiency
Published in The EMBO journal (15-02-2022)“…Haploinsufficiency of the progranulin (PGRN)‐encoding gene ( GRN ) causes frontotemporal lobar degeneration ( GRN ‐FTLD) and results in microglial…”
Get full text
Journal Article -
9
Assessment of 18FPI-2620 Tau-PET Quantification via Non-Invasive Automatized Image Derived Input Function
Published in European journal of nuclear medicine and molecular imaging (01-09-2024)“…[18F]PI-2620 positron emission tomography (PET) detects misfolded tau in progressive supranuclear palsy (PSP) and Alzheimer's disease (AD). We questioned the…”
Get full text
Journal Article -
10
Assessment of [18F]PI-2620 Tau-PET Quantification via Non-Invasive Automatized Image Derived Input Function
Published in European journal of nuclear medicine and molecular imaging (01-09-2024)“…Purpose [ 18 F]PI-2620 positron emission tomography (PET) detects misfolded tau in progressive supranuclear palsy (PSP) and Alzheimer’s disease (AD). We…”
Get full text
Journal Article -
11
Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies
Published in Molecular psychiatry (01-10-2023)“…β-amyloid (Aβ) and tau aggregation as well as neuronal injury and atrophy (ATN) are the major hallmarks of Alzheimer’s disease (AD), and biomarkers for these…”
Get full text
Journal Article -
12
Association of Neurofilament Light Chain, [ 18 F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With β-Amyloid-Negative CBS
Published in Neurology (09-01-2024)“…Corticobasal syndrome (CBS) with underlying 4-repeat tauopathy is a progressive neurodegenerative disease characterized by declining cognitive and motor…”
Get full text
Journal Article -
13
Neuroinflammation Parallels 18F‐PI‐2620 Positron Emission Tomography Patterns in Primary 4‐Repeat Tauopathies
Published in Movement disorders (01-09-2024)“…Background Preclinical, postmortem, and positron emission tomography (PET) imaging studies have pointed to neuroinflammation as a key pathophysiological…”
Get full text
Journal Article -
14
Loss of TMEM 106B potentiates lysosomal and FTLD ‐like pathology in progranulin‐deficient mice
Published in EMBO reports (05-10-2020)Get full text
Journal Article -
15
Subcortical tau is linked to hypoperfusion in connected cortical regions in 4-repeat tauopathies
Published in Brain (London, England : 1878) (05-07-2024)“…4-repeat (4R) tauopathies are neurodegenerative diseases characterized by cerebral accumulation of 4R tau pathology. The most prominent 4R-tauopathies are…”
Get full text
Journal Article -
16
Tau accumulation is associated with dopamine deficiency in vivo in four-repeat tauopathies
Published in European journal of nuclear medicine and molecular imaging (01-06-2024)“…Purpose We hypothesized that severe tau burden in brain regions involved in direct or indirect pathways of the basal ganglia correlate with more severe…”
Get full text
Journal Article -
17
Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia
Published in Molecular neurodegeneration (11-06-2022)“…Genetic mutations underlying familial Alzheimer's disease (AD) were identified decades ago, but the field is still in search of transformative therapies for…”
Get full text
Journal Article -
18
Combining cerebrospinal fluid and PI‐2620 tau‐PET for biomarker‐based stratification of Alzheimer's disease and 4R‐tauopathies
Published in Alzheimer's & dementia (01-10-2024)“…INTRODUCTION Recent advances in biomarker research have improved the diagnosis and monitoring of Alzheimer's disease (AD), but in vivo biomarker‐based…”
Get full text
Journal Article -
19
Biomarker interplay between CSF p‐tau and 18 F‐PI‐2620 PET in Alzheimer’s disease and 4R‐tauopathy
Published in Alzheimer's & dementia (01-12-2023)“…Abstract Background Reliable biomarkers for detecting different abnormal tau protein isoforms between neurodegenerative diseases are currently missing…”
Get full text
Journal Article -
20
Biomarker interplay between CSF p‐tau and 18F‐PI‐2620 PET in Alzheimer’s disease and 4R‐tauopathy
Published in Alzheimer's & dementia (01-12-2023)“…Background Reliable biomarkers for detecting different abnormal tau protein isoforms between neurodegenerative diseases are currently missing. Phosphorylated…”
Get full text
Journal Article